- Home
- SNBR vs VNDA Comparison
SNBR vs VNDA Comparison
Compare SNBR & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- VNDA
- Stock Information
- Founded
- SNBR 1987
- VNDA 2002
- Country
- SNBR United States
- VNDA United States
- Employees
- SNBR N/A
- VNDA N/A
- Industry
- SNBR Home Furnishings
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- SNBR Consumer Discretionary
- VNDA Health Care
- Exchange
- SNBR Nasdaq
- VNDA Nasdaq
- Market Cap
- SNBR 213.8M
- VNDA 249.4M
- IPO Year
- SNBR 1998
- VNDA 2006
- Fundamental
- Price
- SNBR $11.13
- VNDA $4.36
- Analyst Decision
- SNBR Hold
- VNDA Strong Buy
- Analyst Count
- SNBR 2
- VNDA 2
- Target Price
- SNBR $9.00
- VNDA $16.50
- AVG Volume (30 Days)
- SNBR 978.0K
- VNDA 540.9K
- Earning Date
- SNBR 07-30-2025
- VNDA 07-31-2025
- Dividend Yield
- SNBR N/A
- VNDA N/A
- EPS Growth
- SNBR N/A
- VNDA N/A
- EPS
- SNBR N/A
- VNDA N/A
- Revenue
- SNBR $1,524,620,000.00
- VNDA $203,467,000.00
- Revenue This Year
- SNBR N/A
- VNDA $16.86
- Revenue Next Year
- SNBR $4.27
- VNDA $39.78
- P/E Ratio
- SNBR N/A
- VNDA N/A
- Revenue Growth
- SNBR N/A
- VNDA 11.78
- 52 Week Low
- SNBR $4.48
- VNDA $3.81
- 52 Week High
- SNBR $20.75
- VNDA $5.55
- Technical
- Relative Strength Index (RSI)
- SNBR 68.63
- VNDA 44.63
- Support Level
- SNBR $8.44
- VNDA $4.30
- Resistance Level
- SNBR $11.09
- VNDA $4.47
- Average True Range (ATR)
- SNBR 0.92
- VNDA 0.14
- MACD
- SNBR 0.31
- VNDA 0.00
- Stochastic Oscillator
- SNBR 97.50
- VNDA 29.33
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.